*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes - as a primary diagnosis code | C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 7.61 | |
Readmission Rate (%) | 25.66 | |
Unplanned Readmission Rate (%) | 18.26 | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 824: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 821: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 823: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 25,646 | ||||
Total Hospitalizations with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 396 | ||||
DRG Share of Total Hospitalizations | 0.08 | ||||
% of Total ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes in DRG | 25.53 | ||||
Avg LOS at DRG | 5.67 | ||||
Avg LOS with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 4.55 | ||||
Readmission Rate at DRG | 36.28 | ||||
Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 30.94 | ||||
Unplanned Readmission Rate at DRG | 22.95 | ||||
Unplanned Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 23.76 | ||||
Total Medicare payments at DRG | $299,718,477 | ||||
Total Medicare payments with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $4,406,933 | ||||
Total Medicare payment per Day at DRG | $2,062 | ||||
Total Medicare payment per Day with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $2,446 | ||||
Total Medicare payment per Hospitalization at DRG | $11,687 | ||||
Total Medicare payment per Hospitalization with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $11,129 | ||||
Total Medicare Charges at DRG | $1,432,739,779 | ||||
Total Medicare Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $16,237,725 | ||||
Avg Charges at DRG | $55,866 | ||||
Avg Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $41,004 | ||||
Mortality Rate at DRG | 2.6 | ||||
Mortality Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 3.28 | ||||
SNF Discharge Rate at DRG | 13.23 | ||||
SNF Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 7.58 | ||||
Home Discharge Rate at DRG | 49.84 | ||||
Home Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 53.54 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 825: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 822: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 820: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 842: LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|
Total Hospitalizations at DRG | 2,522 | |||
Total Hospitalizations with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 82 | |||
DRG Share of Total Hospitalizations | 0.01 | |||
% of Total ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes in DRG | 5.29 | |||
Avg LOS at DRG | 3.23 | |||
Avg LOS with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 3.43 | |||
Readmission Rate at DRG | 21.79 | |||
Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | NA | |||
Unplanned Readmission Rate at DRG | 11.49 | |||
Unplanned Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | NA | |||
Total Medicare payments at DRG | $21,131,042 | |||
Total Medicare payments with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $741,115 | |||
Total Medicare payment per Day at DRG | $2,596 | |||
Total Medicare payment per Day with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $2,637 | |||
Total Medicare payment per Hospitalization at DRG | $8,379 | |||
Total Medicare payment per Hospitalization with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $9,038 | |||
Total Medicare Charges at DRG | $131,395,939 | |||
Total Medicare Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $4,495,276 | |||
Avg Charges at DRG | $52,100 | |||
Avg Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $54,820 | |||
Mortality Rate at DRG | NA | |||
Mortality Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | NA | |||
SNF Discharge Rate at DRG | 5.27 | |||
SNF Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | NA | |||
Home Discharge Rate at DRG | 79.46 | |||
Home Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 86.59 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 47 |
MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 32 |
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 23 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 406: PANCREAS, LIVER AND SHUNT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 375: DIGESTIVE MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 169,880 | ||||
Total Hospitalizations with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 8,829 | ||||
DRG Share of Total Hospitalizations | 0.52 | ||||
% of Total ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes in DRG | 16.26 | ||||
Avg LOS at DRG | 7.24 | ||||
Avg LOS with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 6.9 | ||||
Readmission Rate at DRG | 16.58 | ||||
Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 13.8 | ||||
Unplanned Readmission Rate at DRG | 10.87 | ||||
Unplanned Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 9.23 | ||||
Total Medicare payments at DRG | $2,683,693,576 | ||||
Total Medicare payments with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $140,393,957 | ||||
Total Medicare payment per Day at DRG | $2,183 | ||||
Total Medicare payment per Day with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $2,306 | ||||
Total Medicare payment per Hospitalization at DRG | $15,798 | ||||
Total Medicare payment per Hospitalization with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $15,901 | ||||
Total Medicare Charges at DRG | $13,978,014,634 | ||||
Total Medicare Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $691,243,477 | ||||
Avg Charges at DRG | $82,282 | ||||
Avg Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $78,292 | ||||
Mortality Rate at DRG | 0.35 | ||||
Mortality Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 0.32 | ||||
SNF Discharge Rate at DRG | 14.58 | ||||
SNF Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 13.8 | ||||
Home Discharge Rate at DRG | 53.56 | ||||
Home Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 57.97 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 374: DIGESTIVE MALIGNANCY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 405: PANCREAS, LIVER AND SHUNT PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 436: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 40,116 | ||||
Total Hospitalizations with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 1,423 | ||||
DRG Share of Total Hospitalizations | 0.12 | ||||
% of Total ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes in DRG | 2.62 | ||||
Avg LOS at DRG | 6.14 | ||||
Avg LOS with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 6.67 | ||||
Readmission Rate at DRG | 26.88 | ||||
Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 26.44 | ||||
Unplanned Readmission Rate at DRG | 18.3 | ||||
Unplanned Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 19.14 | ||||
Total Medicare payments at DRG | $472,915,537 | ||||
Total Medicare payments with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $18,492,207 | ||||
Total Medicare payment per Day at DRG | $1,921 | ||||
Total Medicare payment per Day with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $1,947 | ||||
Total Medicare payment per Hospitalization at DRG | $11,789 | ||||
Total Medicare payment per Hospitalization with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $12,995 | ||||
Total Medicare Charges at DRG | $2,356,079,688 | ||||
Total Medicare Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $89,860,325 | ||||
Avg Charges at DRG | $58,732 | ||||
Avg Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $63,149 | ||||
Mortality Rate at DRG | 10.79 | ||||
Mortality Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 12.86 | ||||
SNF Discharge Rate at DRG | 10.16 | ||||
SNF Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 8.36 | ||||
Home Discharge Rate at DRG | 35.89 | ||||
Home Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 32.89 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 326: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 39,906 | ||||
Total Hospitalizations with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 883 | ||||
DRG Share of Total Hospitalizations | 0.12 | ||||
% of Total ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes in DRG | 1.63 | ||||
Avg LOS at DRG | 12.58 | ||||
Avg LOS with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 16.86 | ||||
Readmission Rate at DRG | 30.9 | ||||
Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 31.54 | ||||
Unplanned Readmission Rate at DRG | 16.7 | ||||
Unplanned Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 17.41 | ||||
Total Medicare payments at DRG | $1,415,372,711 | ||||
Total Medicare payments with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $35,873,798 | ||||
Total Medicare payment per Day at DRG | $2,820 | ||||
Total Medicare payment per Day with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $2,410 | ||||
Total Medicare payment per Hospitalization at DRG | $35,468 | ||||
Total Medicare payment per Hospitalization with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $40,627 | ||||
Total Medicare Charges at DRG | $6,367,247,472 | ||||
Total Medicare Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $184,762,776 | ||||
Avg Charges at DRG | $159,556 | ||||
Avg Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $209,244 | ||||
Mortality Rate at DRG | 9.11 | ||||
Mortality Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 11.1 | ||||
SNF Discharge Rate at DRG | 24.69 | ||||
SNF Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 21.63 | ||||
Home Discharge Rate at DRG | 27.39 | ||||
Home Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 19.48 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 499,133 | ||||
Total Hospitalizations with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 566 | ||||
DRG Share of Total Hospitalizations | 1.52 | ||||
% of Total ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes in DRG | 1.04 | ||||
Avg LOS at DRG | 4.34 | ||||
Avg LOS with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 5.12 | ||||
Readmission Rate at DRG | 17.57 | ||||
Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 29.15 | ||||
Unplanned Readmission Rate at DRG | 12.56 | ||||
Unplanned Readmission Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 23.17 | ||||
Total Medicare payments at DRG | $3,254,711,780 | ||||
Total Medicare payments with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $4,642,708 | ||||
Total Medicare payment per Day at DRG | $1,504 | ||||
Total Medicare payment per Day with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $1,601 | ||||
Total Medicare payment per Hospitalization at DRG | $6,521 | ||||
Total Medicare payment per Hospitalization with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $8,203 | ||||
Total Medicare Charges at DRG | $16,863,396,143 | ||||
Total Medicare Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $24,790,472 | ||||
Avg Charges at DRG | $33,785 | ||||
Avg Charges with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | $43,799 | ||||
Mortality Rate at DRG | 1.33 | ||||
Mortality Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 2.65 | ||||
SNF Discharge Rate at DRG | 19.89 | ||||
SNF Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 11.48 | ||||
Home Discharge Rate at DRG | 49.27 | ||||
Home Discharge Rate with ICD C772 - Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes | 45.41 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 2,713 |
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 674 |
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 540 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. PETER J ALLEN | 1275 YORK AVE | NEW YORK | NY | 10021 | 103 |
Dr. WILLIAM R JARNAGIN | 1275 YORK AVE | NEW YORK | NY | 10021 | 97 |
Dr. MARTIN R WEISER | 1275 YORK AVE | NEW YORK | NY | 10021 | 67 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. WILLIAM R JARNAGIN | 1275 YORK AVE | NEW YORK | NY | 10021 | 168 |
Dr. PETER J ALLEN | 1275 YORK AVE | NEW YORK | NY | 10021 | 125 |
Dr. CHHAVI BANSAL KUMAR | 550 1ST AVE | NEW YORK | NY | 10016 | 111 |